Explore

Iterate

Vision

Xilio Therapeutics

Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer.

Industries

Biotechnology, Health Care

+2

Headquarters

Waltham, United States

Stage

Series C

Employees

11-50

Links

Org chart

Rene Russo
CEO
Collapse
Sal Giovine
CFO
Uli Bialucha
Chief Scientific Officer
Stacey Davis
Chief Business Officer
Chris Frankenfield
Chief Legal & Administrative Officer
Marty Huber
President of R&D & Chief Medical Officer

Teams

View all

AL
AO
CH
+13

Board of Directors

16 members

+3

CEO and Executive Team

6 members

+3

Leadership Team

6 members

Discover similar companies

Neuron23 logo

Neuron23

Series C • South San Francisco, United States

Apollomics logo

Apollomics

Series C • Foster City, United States

Enko logo

Enko

Series C • Stonington, United States

Cullinan logo

Cullinan

Series C • Cambridge, United States

Checkmate Pharmaceuticals logo

Checkmate Pharmaceuticals

Series C • Cambridge, United States

Adagio Therapeutics logo

Adagio Therapeutics

Series C • Waltham, United States

Vizgen logo

Vizgen

Series C • Cambridge, United States

Encodia logo

Encodia

Series C • San Diego, United States

Halo Labs logo

Halo Labs

Series C • Philadelphia, United States

HotSpot Therapeutics logo

HotSpot Therapeutics

Series C • Boston, United States

BioAge logo

BioAge

Series C • Richmond, United States

DiscGenics logo

DiscGenics

Series C • Salt Lake City, United States

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.

Resources

About The OrgSupportCompaniesPeopleTeams

Solutions

Vision - Lead GenPartner with usHubSpot CRM Integration

Iterate

Employer BrandingJob TitlesTalent AcquisitionInterview QuestionsOrganizational StructureOnboardingPeople AnalyticsEmployee Engagement & RetentionNews

Visit us at

The OrgFacebookTwitter
© 2023 Orgio, Inc.
TermsPrivacyData